Search for: "WIT ASSOCIATES, INC. v. US " Results 341 - 360 of 1,232
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2018, 7:32 pm by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989) (“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
31 Oct 2018, 11:21 am by John Elwood
(relisted after the October 26 conference)   AT&T, Inc v. [read post]
20 Oct 2018, 8:50 am by Schachtman
Ensign-Bickford Industries, Inc.,15 permitted plaintiffs’ expert witness to reanalyze a study by grouping together two previously distinct cancer outcomes to generate a statistically significant result. [read post]
19 Oct 2018, 4:30 am by John-Paul Boyd
I also encourage anyone who’s interested to take this document (if you contact me by email, I will send you a draft in Word format) for adaptation, reuse and repurposing; I assert no copyright or other moral rights in this document apart from the right to be associated with it as author. [read post]
15 Oct 2018, 8:16 am by Steven Cohen
Facts:  This case (NEW JERSEY PRIMARY CARE ASSOCIATION, INC. v. [read post]
5 Oct 2018, 7:43 pm by Schachtman
DePuy Orthopaedics, Inc., Nos. 16-11051, et al., 2018 U.S. [read post]
23 Sep 2018, 4:03 pm by Schachtman
Perhaps Cranor’s most notorious appearance as an expert witness resulted in the decision of Milward v. [read post]
25 Aug 2018, 1:06 pm by Kelsey Farish
Disney has responded to the copyright lawsuit lodged earlier this year in California by the Estate of Michael Jackson (MJJ Productions (et al) v Walt Disney Company and ABC INC). [read post]
16 Aug 2018, 6:15 pm by Schachtman
Pledger v Janssen Pharms, Inc., Phila. [read post]
7 Aug 2018, 9:07 am by John Jascob
” The witnesses included virtual currency entrepreneurs, academics, an attorney, and a government regulator, all seeking to shed light on the promise of digital assets and the regulatory challenges associated with these novel products. [read post]